Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company
Aurobindo Pharma USA receives FTC approval to acquire Lannett Company in a USD 250 million deal. The transaction is expected to close before the end of June 2026.
Aurobindo Pharma USA | 22/06/2026 | By News Bureau
Aurobindo Pharma USA To Acquire Lannett For USD 250 Million, Enter ADHD Treatment Space
Aurobindo Pharma USA Inc., has entered into a definitive agreement to acquire 100 percent membership interest in Lannett Company LLC from its parent company, Lannett Seller Holdco, Inc.
Aurobindo Pharma USA | 31/07/2025 | By Dineshwori | 597
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy